Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes September 1975 24:801-810; doi:10.2337/diabetes.24.9.801
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes September 1975 24:842-850; doi:10.2337/diabetes.24.9.842
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Marked hyperthermia as a manifestation of hypoglycemia in long-standing diabetes mellitus. Diabetes September 1975 24:859-860; doi:10.2337/diabetes.24.9.859
Marked hyperthermia as a manifestation of hypoglycemia in long-standing diabetes mellitus. Diabetes September 1975 24:859-860; doi:10.2337/diabetes.24.9.859
Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes September 1975 24:801-810; doi:10.2337/diabetes.24.9.801
Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes September 1975 24:842-850; doi:10.2337/diabetes.24.9.842
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes September 1975 24:842-850; doi:10.2337/diabetes.24.9.842
Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis. Diabetes September 1975 24:851-855; doi:10.2337/diabetes.24.9.851
Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes September 1975 24:801-810; doi:10.2337/diabetes.24.9.801
Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis. Diabetes September 1975 24:851-855; doi:10.2337/diabetes.24.9.851
Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis. Diabetes September 1975 24:851-855; doi:10.2337/diabetes.24.9.851
Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes September 1975 24:801-810; doi:10.2337/diabetes.24.9.801
Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes September 1975 24:801-810; doi:10.2337/diabetes.24.9.801
Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis. Diabetes September 1975 24:851-855; doi:10.2337/diabetes.24.9.851
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes September 1975 24:842-850; doi:10.2337/diabetes.24.9.842
Immunoreactive glucagon responses to intravenous tolbutamide in chronic pancreatitis. Diabetes September 1975 24:851-855; doi:10.2337/diabetes.24.9.851
Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.
Diabetes September 1975 24:820-828; doi:10.2337/diabetes.24.9.820
Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes September 1975 24:842-850; doi:10.2337/diabetes.24.9.842